| 000 | 01764 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250516090856.0 | ||
| 264 | 0 | _c20121025 | |
| 008 | 201210s 0 0 eng d | ||
| 022 | _a1873-2518 | ||
| 024 | 7 |
_a10.1016/j.vaccine.2012.04.032 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _ade Haan, Aalzen | |
| 245 | 0 | 0 |
_aBacterium-like particles supplemented with inactivated influenza antigen induce cross-protective influenza-specific antibody responses through intranasal administration. _h[electronic resource] |
| 260 |
_bVaccine _cJul 2012 |
||
| 300 |
_a4884-91 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAdjuvants, Immunologic _xadministration & dosage |
| 650 | 0 | 4 | _aAdministration, Intranasal |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Viral _xblood |
| 650 | 0 | 4 | _aAntibody Formation |
| 650 | 0 | 4 | _aAntibody Specificity |
| 650 | 0 | 4 |
_aAntigens, Viral _ximmunology |
| 650 | 0 | 4 | _aCross Protection |
| 650 | 0 | 4 | _aHemagglutination Inhibition Tests |
| 650 | 0 | 4 | _aImmunity, Mucosal |
| 650 | 0 | 4 |
_aImmunoglobulin G _xblood |
| 650 | 0 | 4 | _aInfluenza A Virus, H1N1 Subtype |
| 650 | 0 | 4 |
_aInfluenza Vaccines _xadministration & dosage |
| 650 | 0 | 4 |
_aLactococcus lactis _ximmunology |
| 650 | 0 | 4 |
_aLung _xvirology |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred BALB C |
| 650 | 0 | 4 |
_aOrthomyxoviridae Infections _ximmunology |
| 650 | 0 | 4 |
_aVaccines, Inactivated _xadministration & dosage |
| 700 | 1 | _aHaijema, Bert Jan | |
| 700 | 1 | _aVoorn, Petra | |
| 700 | 1 | _aMeijerhof, Tjarko | |
| 700 | 1 | _avan Roosmalen, Maarten L | |
| 700 | 1 | _aLeenhouts, Kees | |
| 773 | 0 |
_tVaccine _gvol. 30 _gno. 32 _gp. 4884-91 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.vaccine.2012.04.032 _zAvailable from publisher's website |
| 999 |
_c21735822 _d21735822 |
||